PROCTER & GAMBLE HEALTH
|
The Current P/B Ratio of PROCTER & GAMBLE HEALTH is 19.04.
Share Price | ₹6,102.4 | Oct 13,2025 |
Market Cap | ₹10,129.9 Cr | |
Book Value | ₹532.1 Cr | Mar2025 - Standalone Results |
Price/Book | 19.04x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of PROCTER & GAMBLE HEALTH
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹10,129.9 Cr] as on Oct 13,2025
(/) Book Value [ ₹532.1 Cr] based on Mar2025 - Standalone Results
(=) P/B Ratio [ 19.04x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '19.04 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/B Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PB (Price/Book ) ratio chart of PROCTER & GAMBLE HEALTH
PB Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/b ratio for fiscal years ending Mar2025 to Jun2022 averaged 13.95x.
- PROCTER & GAMBLE HEALTH 's operated at median p/b ratio of 14.75x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/b ratio peaked in Mar2025 at 16.04x.
- PROCTER & GAMBLE HEALTH 's p/b ratio hit its five-year low in Jun2022 of 11.41x.
How does PROCTER & GAMBLE HEALTH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
PROCTER & GAMBLE HEALTH | 532.07 | 19.04 | 10,129.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.54 | 400,329.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 11.62 | 173,991.0 |
CIPLA LTD | 31,079.30 | 4.06 | 126,326.0 |
TORRENT PHARMACEUTICALS LTD | 7,590.69 | 15.69 | 119,126.0 |
DR REDDYS LABORATORIES LTD | 33,404.90 | 3.15 | 105,324.0 |
MANKIND PHARMA LTD | 14,288.70 | 7.05 | 100,787.0 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.17 | 99,974.4 |
LUPIN LTD | 17,119.50 | 5.26 | 89,997.9 |
AUROBINDO PHARMA LTD | 32,653.30 | 2.02 | 66,022.6 |
ABBOTT INDIA LTD | 4,204.27 | 15.14 | 63,663.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PROCTER & GAMBLE HEALTH 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.02x |
Max industry PB | 19.04x |
Median industry PB | 5.54x |
Average industry PB | 8.43x |
You may also like the below Video Courses